FDA, Justice Department make it easier to obtain abortion drugs through pharmacies and mail

Abortion drugs mifepristone and misoprostol
(Image credit: Robyn Beck/AFP via Getty Images)

The Food and Drug Administration quietly finalized regulatory changes on Tuesday that allow retail pharmacies to dispense the abortion pill mifepristone, so long as it is prescribed by a certified health-care provider and the pharmacy meets certain requirements. Mifepristone, taken with the drug misoprostol to terminate pregnancies in the first trimester, was previously available only at specialty clinics and from certain mail-order pharmacies.

Most U.S. abortions are now done with pills rather than surgery, according to the Guttmacher Institute. Access to medication abortion has become a central focus of abortion rights and antiabortion advocates after the Supreme Court ended the federal right to abortion in June 2022. The FDA lifted bans on doctors prescribing abortion pills via telehealth consultations and home delivery of the medications in 2021.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.